Crescent Capital Group
Crescent Capital Group is a $53bn corporate credit manager within SLC Management whose lending strategies start at €5m of EBITDA in Europe and $5m in the US, for private equity-backed companies.
Considering finance for your business? Discuss the lender options.
What they do
Crescent Capital Group is a global investment manager that says its entire focus is corporate credit, invested in private and tradeable markets for more than 30 years. It managed $53bn at 30 June 2026 with 225 people in six offices, and it is part of SLC Management, an institutional alternatives and traditional asset management business. The private credit side runs three corporate lending strategies. Crescent Credit Solutions has lent senior and junior debt to the core middle market since 1992, globally, to private equity-backed businesses with $50m to $150m or more of EBITDA. Crescent Direct Lending has provided senior debt to US lower-mid-market companies since 2005, and Crescent European Specialty Lending has made senior and unitranche loans to European lower-mid-market companies since 2014, with room for junior debt. Alongside them sit a GP financing strategy for sponsors and a bank risk-sharing strategy, while tradeable credit covers high yield, bank loans and a CLO platform dating from 1993. Its lowest published floor is €5m of EBITDA, so Crescent lends above this market.
Who they lend to
Every corporate lending strategy Crescent publishes is aimed at private equity-backed companies, and each states the borrower size it wants in EBITDA. In Europe, Crescent European Specialty Lending targets lower-mid-market businesses with €5m to €25m of EBITDA. In the US, Crescent Direct Lending serves sponsor-owned companies with $5m to $50m of EBITDA, while Crescent Credit Solutions invests globally at $50m to $150m or more. Sector appetite is broad: the US direct lending team has lent to more than 285 companies in a variety of industries alongside over 150 distinct sponsors since 2005, and a June 2025 paper argued for the financial services sector. No country list is published for Europe, but the firm has offices in London and Frankfurt, and Private Debt Investor named it lower mid-market lender of the year in Europe in March 2025.
How they structure a facility
In Europe the product is senior and unitranche lending, with flexibility to add junior financing; in the US it is senior secured debt for leveraged buyouts, acquisition financing, refinancings and recapitalisations. Crescent Credit Solutions spans senior and junior private credit for larger companies. Tenor, amortisation, covenant style, leverage multiples and pricing go unpublished for every strategy. The figures it does publish describe the capital behind its loans. The fourth US direct lending fund closed in June 2026 with $10.8bn of investable capital, counting targeted leverage and separately managed accounts, on equity commitments above $5.5bn from more than 100 institutions in 18 countries. Its third European fund closed in April 2025 at about €3bn, against a €2bn target. Investors include insurers, pension funds and sovereign wealth funds, and in April 2026 the UK pension fund Nest awarded Crescent a £450m US direct lending mandate.
How a deal reaches them
Crescent puts private equity sponsors at the centre of its origination: its pages cite long-standing relationships with sponsors and borrowers, a proprietary transaction-sourcing platform and investments alongside hundreds of sponsors since inception. Its private credit page also invites borrowers looking for debt financing to make contact. The London office is at 2 Cavendish Square, W1G 0PU, and a Frankfurt office covers the DACH region. Crescent publishes no account of its credit process or decision times, though its US direct lending team says borrowers and sponsors value its reliable execution and speed of close. It does not list the information it needs before offering terms.
Where they fit in a lower-mid-market raise
For a UK company below its floors, Crescent is useful as a definition. What this manager calls the lower middle market begins in Europe at €5m of EBITDA, and it raised about €3bn for its third European fund and $10.8bn for its fourth US fund to lend in that segment. A business in Europe earning less than €5m of EBITDA falls below the range Crescent publishes for the region, whatever the quality of its sponsor. The comparison also shows how institutional direct lending deploys. By June 2026 the fourth US fund had committed about $2.7bn of senior loans to more than 60 companies, roughly 40% of its capital, pacing ahead of schedule. A company that grows through €5m of EBITDA under private equity ownership moves into the range Crescent lends to, and the firm keeps a London office.
Where they are not the fit
A company without a private equity sponsor is the clearest mismatch, because each published lending strategy is built around sponsor-backed borrowers. Size is the second: a company below €5m of EBITDA in Europe, or $5m in the US, is under the floor of the relevant lower-mid-market strategy. Working capital, asset finance and invoice finance are absent from its product set, which leaves owner-managed companies looking for them with no fit. The GP financing and bank risk-sharing strategies serve private equity firms and banks rather than operating companies. Crescent prints no pricing, so a borrower cannot set its margin against a bank's offer from anything the firm publishes.
What rules a deal out
Stated limits, taken from Crescent Capital Group’s own published criteria. A limit is where a lender starts from, not where it always ends: several of these move on a strong enough credit.
- No private equity sponsor
- EBITDA under €5m in Europe or $5m in the US
How they sit against the category
- Like 59 of the 60, it publishes no indicative price; a margin comes from a conversation, not a page.
Counted across the 60 private-credit & direct-lending funds in this directory, on what each one publishes. What a lender discloses and what it will do are different things.
Recent activity on the public record
In August 2026, Crescent closed its second CLO equity fund at $232m, double the $103m raised by its 2018 predecessor. In June 2026, its fourth US direct lending fund closed at $10.8bn of investable capital, the largest fund in the firm's history, beating its initial target by more than $2.5bn. In April 2026, Nest appointed it to a £450m US direct lending mandate, and in January 2026 it closed a $3.2bn private credit continuation vehicle with Pantheon. In August 2025, it launched a GP financing strategy for sponsors, and in April 2025 its third European specialty lending fund closed at about €3bn.
8 dated items, 2024 to 2026, numbered as listed below.
| No. | Date | Item |
|---|---|---|
| 01 | Dec 2024 | Crescent closed Atlas Senior Loan Fund XXIV, a $400m collateralised loan obligation. |
| 02 | Mar 2025 | Private Debt Investor named Crescent lower mid-market lender of the year in Europe. |
| 03 | Apr 2025 | Crescent closed its third European specialty lending fund, CESL III, at about €3bn of investable capital, above its €2bn target. |
| 04 | Aug 2025 | Crescent launched a GP financing solutions strategy providing growth capital to private equity sponsors. |
| 05 | Jan 2026 | Crescent closed a $3.2bn private credit continuation vehicle with Pantheon. |
| 06 | Apr 2026 | UK pension fund Nest appointed Crescent to a £450m US direct lending mandate. |
| 07 | Jun 2026 | Crescent closed its fourth US direct lending fund, CDL Fund IV, at $10.8bn of investable capital, the largest fund in its history. |
| 08 | Aug 2026 | Crescent closed its second CLO equity fund, Crescent CLO Equity Funding II, at $232m, double the size of its predecessor. |
A disc is an item that carries a facility amount, sized to it; a tick is an item without one.
On the record
December 2024: Crescent closed Atlas Senior Loan Fund XXIV, a $400m collateralised loan obligation.
March 2025: Private Debt Investor named Crescent lower mid-market lender of the year in Europe.
April 2025: Crescent closed its third European specialty lending fund, CESL III, at about €3bn of investable capital, above its €2bn target.
August 2025: Crescent launched a GP financing solutions strategy providing growth capital to private equity sponsors.
January 2026: Crescent closed a $3.2bn private credit continuation vehicle with Pantheon.
April 2026: UK pension fund Nest appointed Crescent to a £450m US direct lending mandate.
June 2026: Crescent closed its fourth US direct lending fund, CDL Fund IV, at $10.8bn of investable capital, the largest fund in its history.
August 2026: Crescent closed its second CLO equity fund, Crescent CLO Equity Funding II, at $232m, double the size of its predecessor.
Questions this page answers
What size of European company does Crescent Capital Group lend to?
Crescent European Specialty Lending, running since 2014, makes senior and unitranche loans, with flexibility for junior financing, to private equity-backed European lower-mid-market companies with €5m to €25m of EBITDA.
As published at crescentcap.com
Does Crescent Capital Group lend without a private-equity sponsor?
Its published lending strategies all describe private equity-backed borrowers, and its GP financing strategy lends to the sponsors themselves. Crescent describes no product for owner-managed companies without a sponsor.
As published at crescentcap.com
How large is Crescent Capital Group's US direct lending business?
Crescent Direct Lending says it has issued more than $17.0bn of loan commitments to over 285 companies since 2005, backed by more than 150 private equity sponsors, lending to US companies with $5m to $50m of EBITDA.
As published at crescentcap.com
Who owns Crescent Capital Group?
Crescent is part of SLC Management, which its site describes as an institutional alternatives and traditional asset management business. The firm operates as Crescent Capital Group LP together with its subsidiaries and affiliates.
As published at crescentcap.com
Where is Crescent Capital Group's London office?
Crescent lists its London office at 2 Cavendish Square, London W1G 0PU, telephone +44 20 3696 5420. The firm is headquartered in the US and also has an office in Frankfurt.
As published at crescentcap.com
How quickly does Crescent Capital Group give terms?
Crescent publishes no timetable. Its US direct lending team says a larger capital base lets it keep offering the reliable execution and speed of close that borrowers and sponsors value, without putting a number on it.
As published at crescentcap.com
What does Crescent Capital Group charge borrowers?
Crescent does not publish margins, fees or a pricing range for any lending strategy. Its site describes the returns it targets for investors, not the terms a borrower would pay.
As published at crescentcap.com
Sources: crescentcap.com · crescentcap.com · crescentcap.com · crescentcap.com · crescentcap.com · crescentcap.com
Terms used on this page: Unitranche · Mezzanine · Amortisation · Direct lender · Sponsor
This profile is a curated reference note drawn from public sources, not financial advice or a recommendation. Appetite and terms change; a lender's fit for a given credit is established by approaching it, not inferred from a page.